BTNL2 and neoplasm: Very recently a mechanism of immune evasion by expression of BTNL2 on cancer cells was described, where BTNL2 promotes IL-17 production by a local γδ T cell population which enhances tumor resistance by recruitment of myeloid suppressor cells T cells (39).